Helix Nanotechnologies
Edit info- Founded: 2013
- Location: Cambridge, MA
- Employee range: 11 - 50
- Clinical stage: RD
- Therapy area: COVID-19
- Drug types: VAC, INF, ONC
- Lead product: Undisclosed
- Funding: 10-100M
helixnano.com linkedin.com job board
Business:
DNA Therapy
Drug notes:
Undisclosed RD oncology
About:
HelixNano is using artificial intelligence to treat genetic diseases. Messenger RNA (mRNA) contains information for a cell to make proteins, analogous to how technology finds information and delivers physical products. HelixNano is leveraging mRNA and improving its capabilities using first principles to enhance the speed and reduce the cost to develop therapies for genetic diseases. In particular, HelixNano is focusing on mRNA vaccines, recently pivoting from cancer therapies to creating better, second-generation, mutation-resistant Covid-19 vaccines. HelixNano has developed new vaccine technologies, which have a ‘zoom’ function and an ‘amplify’ function to rival current vaccines. HelixNano is also interested in creating topologically-applied vaccines that are stable at room temperature.
Jobs:
News:
Massachusetts biotech startups making progress on coronavirus tests, vaccines
crunchbase
May 9, 2020
Science/business updates
external-link
This biotech start-up is working overtime to develop a second-wave, mutation-resistant Covid-19 vaccine - CNBC
googlenews
Mar 29, 2021
Science/business updates
external-link
What it’s like to invent a coronavirus vaccine in the middle of a pandemic
crunchbase
Apr 24, 2020
Science/business updates
external-link
Brunch with Plural and HelixNano’s Carina Namih: I needed to go to Silicon Valley to find VCs who could ‘match my ambition’
crunchbase
Apr 26, 2024
Funding-related
external-link
Group run by former Google CEO to hold meeting with VCs, philanthropists about ways to fight coronavirus
crunchbase
Mar 17, 2020
Funding-related
external-link
What it's like to invent a coronavirus vaccine in the middle of a pandemic - CNBC
googlenews
Apr 24, 2020
Science/business updates
external-link
Silicon Valley Ramps Up Efforts to Tackle Virus
crunchbase
Mar 16, 2020
Science/business updates
external-link
Silicon Valley Is Forced to Reset Its Moral Compass for the Pandemic
crunchbase
May 18, 2020
Science/business updates
external-link
HELIXNANO’S SUBSIDIARY, HELIXNANO AUSTRALIA, RECEIVES HREC APPROVAL TO INITIATE A PHASE 1 CLINICAL TRIAL
linkedin
Dec 19, 2024
Science/business updates
external-link
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com